Skip to main content

Sangamo Therapeutics, Inc 10-Q for FY2024 Q2

Sangamo Therapeutics, Inc (SGMOQ)

10-Q 2024-08-06 For: 2024-06-30
View Original
Added on April 10, 2026

About this 10-Q

Sangamo Therapeutics, Inc filed this 10-Q on August 6, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).

Headline figures

Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$356K
down 94.8% from $6.84M a year earlier
Net loss
$36.13M
compared with a net loss of $114.51M a year earlier
Diluted EPS
-$0.18
compared with -$0.66 a year earlier